On average, equities research analysts expect that RAPT Therapeutics, Inc. RAPT Therapeutics had a negative net margin of 1,468.46% and a negative return on equity of 41.61%. The business had revenue of $0.97 million during the quarter, compared to analysts’ expectations of $1.45 million. The company reported ($0.63) EPS for the quarter, missing the consensus estimate of ($0.62) by ($0.01). RAPT Therapeutics (NASDAQ:RAPT) last posted its earnings results on Wednesday, November 10th. The firm has a market capitalization of $897.02 million, a P/E ratio of -12.44 and a beta of 0.13. The stock’s fifty day simple moving average is $33.34 and its 200-day simple moving average is $31.79. has a twelve month low of $14.89 and a twelve month high of $43.26. RAPT Therapeutics stock opened at $30.36 on Wednesday. The shares were sold at an average price of $36.04, for a total value of $108,120.00. On Wednesday, September 8th, William Ho sold 3,000 shares of RAPT Therapeutics stock.The shares were sold at an average price of $38.97, for a total value of $77,940.00. On Friday, September 17th, William Ho sold 2,000 shares of RAPT Therapeutics stock.The stock was sold at an average price of $40.00, for a total value of $80,000.00. On Monday, September 20th, William Ho sold 2,000 shares of RAPT Therapeutics stock.The stock was sold at an average price of $29.69, for a total value of $89,070.00. On Wednesday, October 13th, William Ho sold 3,000 shares of RAPT Therapeutics stock.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |